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Abstract
Transglutaminase 2 (TG2) is a multifunctional protein that promotes clearance of apoptotic cells (efferocytosis) acting
as integrin β3 coreceptor. Accumulating evidence indicates that defective efferocytosis contributes to the
development of chronic inﬂammatory diseases. Obesity is characterized by the accumulation of dead adipocytes and
inﬂammatory macrophages in the adipose tissue leading to obesity-related metabolic syndrome. Here, we report that
loss of TG2 from bone marrow-derived cells sensitizes for high fat diet (HFD)-induced pathologies. We ﬁnd that
metabolically activated TG2 null macrophages express more phospho-Src and integrin β3, unexpectedly clear dying
adipocytes more efﬁciently via lysosomal exocytosis, but produce more pro-inﬂammatory cytokines than the wild type
ones. Anti-inﬂammatory treatment with an LXR agonist reverts the HFD-induced phenotype in mice lacking TG2 in
bone marrow-derived cells with less hepatic steatosis than in wild type mice proving enhanced lipid clearance. Thus it
is interesting to speculate whether LXR agonist treatment together with enhancing lysosomal exocytosis could be a
beneﬁcial therapeutic strategy in obesity.
Introduction
Transglutaminase 2 (TG2) is a unique member of the
transglutaminase family with various biological func-
tions1. Although TG2 is localized predominantly within
the cell, substantial amounts of the protein is present also
on the surface of macrophages functioning as an integrin
β3 coreceptor
2,3. Acting so, TG2 in macrophages pro-
motes phagocytosis of apoptotic cells by stabilizing the
interaction between αvβ3 integrins and the bridging
molecule milk fat globule-EGF-factor 8 (MFG-E8)4,5.
Increasing evidence indicate that impaired clearance of
apoptotic cells is associated with the development of
various chronic inﬂammatory diseases6. This is related to
the fact that (1) uncleared apoptotic cells undergo sec-
ondary necrosis and induce inﬂammation, and (2) mac-
rophages properly engulﬁng apoptotic cells would
normally induce anti-inﬂammatory mechanisms that
prevent tissue inﬂammation. In accordance, in TG2 null
mice following in vivo apoptosis induction, apoptotic cells
are not only accumulated in tissues, but are also sur-
rounded by mononuclear cells7, and their clearance is
accompanied by production of pro-inﬂammatory cyto-
kines8. In addition, TG2 knockout mice develop systemic
lupus erythematosus-like autoimmunity on long term7.
Multiple lines of evidence revealed that obesity is also
characterized by low-grade inﬂammation that originates
from the expanding adipose tissue9. Inﬂammation,
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predominantly in the visceral fat tissue is believed to be
initiated and maintained by BH3 interacting domain
death agonist (Bid)-mediated apoptosis of hypertrophic
lipid overloaded adipocytes10 releasing chemoattractants,
such as monocyte chemoattractant protein-1 (MCP-1)11
to recruit macrophages for their proper clearance. While
adipose tissue macrophages in lean mice have an anti-
inﬂammatory phenotype, recruited macrophages exposed
to high concentrations of lipids switch their phenotype to
the so-called metabolically activated one (MMe) char-
acterized by high rate of lysosomal biogenesis, expression
of CD11c and release of pro-inﬂammatory cytokines and
resistin12,13. Since the size of adipocytes greatly excess
that of the recruited macrophages, instead of being pha-
gocytosed by a single macrophage, dead adipocytes are
cleared by groups of recruited macrophages. It was esti-
mated that >90% of macrophages inﬁltrating the adipose
tissue of obese animals and humans are arranged around
the dead adipocytes forming characteristic crown-like
structures (CLS)14. During this process macrophages form
a tight attachment on the dead adipocyte, acidify the
contact space by activating the plasma membrane proton
pumping V-ATPase and release their lysosomal content
through lysosomal exocytosis machinery15. Initiation of
both the lysosomal exocytosis program and the pro-
inﬂammatory cytokine formation in metabolically acti-
vated macrophages seem to involve TLR2, while TLR4
activation contributes to the pro-inﬂammatory cytokine
formation16,17.
Lipid-loaded adipocytes produce pro-inﬂammatory
cytokines themselves, and the production is positively
correlated with the degree of hypertrophy18. Lipid accu-
mulation also alters adipocyte adipokine synthesis leading
to enhanced release of leptin and resistin, and to
decreased production of adiponectin19. Since adiponectin
increases, while resistin and pro-inﬂammatory cytokines
decrease insulin sensitivity, altogether these changes in
the cytokine and adipokine expressions decrease whole-
body insulin sensitivity leading to compensatory increases
in circulating plasma insulin levels and later to the
development of type-2 diabetes mellitus20–23.
In addition, macrophage-derived TNF-α24,25 and
adipocyte-derived leptin26 also contribute to the cell death
induction of hypertrophic adipocytes. As a result, during
long term obesity more and more hypertrophic adipocytes
die leading to a marked loss of the visceral adipose tissue
size and to relocation of its lipid depots to other tissues,
such as liver, where the lipid accumulation promoted by
TNFα-mediated upregulation of hepatic fatty acid trans-
locase leads to hepatic steatosis27,28.
In the present paper, we investigated whether TG2 is
involved in the clearance of apoptotic adipocytes, and how
its loss affects obesity-related gonadal fat adipocyte
apoptosis, macrophage recruitment, inﬂammation, insulin
resistance, and hepatic steatosis during diet-induced
obesity in mice.
Results
Loss of TG2 does not affect weight gain during diet-
induced obesity, but enhances adipose tissue
inﬂammation
Wild type mice exposed to either high sucrose/high fat
diet (HFD) or to high sucrose diet (HSD) developed
marked obesity compared with animals kept on a stan-
dard control diet (ND) (40.0 ± 5.5 versus 33.9 ± 2.6 versus
27.2 ± 0.6 g body weight of mice kept on HFD, HSD or
ND, respectively, p < 0.01). Loss of TG2 did not affect
signiﬁcantly the weight gain of the animals kept on the
three different types of diet (Fig. 1a).
As seen in Fig. 1b, the gonadal fat tissue (gWAT) weight
also increased signiﬁcantly in both wild type and TG2 null
mice exposed to HSD or HFD as compared to mice kept
on control diet. However, in case of TG2 null mice kept
on HFD the gonadal fat was signiﬁcantly less than in wild
type mice kept on HFD very likely due to the enhanced
adipocyte apoptosis in TG2 null gonadal fat at this time
point (see later).
Loss of TG2 did not affect the obesity-related altera-
tions in the expression levels of the adiponectin and
resistin (Fig. 1c), but obesity-induced expressions of TNF-
α, MCP-1, and leptin were signiﬁcantly enhanced in the
gWAT adipocytes of TG2 null animals as compared to
wild type mice (Fig. 1c).
HSD and HFD signiﬁcantly induced the mRNA
expression of the pro-inﬂammatory cytokines in adipose
tissue macrophages as well, which was more pronounced
in the absence of TG2 (Fig. 1d). All these data indicate
that though loss of TG2 does not affect weight gain,
inﬂammation is much more pronounced in the gWAT of
TG2 null animals during diet-induced obesity.
Enhanced adipocyte apoptosis in the gonadal fat during
diet-induced obesity in TG2−/− mice
As obesity promotes adipocyte death, we decided to
determine the expression of various pro- and anti-
apoptotic genes in the adipocytes of gWAT. As seen in
Supplementary Fig. S1, in the gWAT adipocytes not only
the expression of the pro-apoptotic Bid, but the expres-
sion of the pro-apoptotic Bim was also induced during
diet-induced obesity.
Interestingly, not only the pro-apoptotic, but mRNAs of
two anti-apoptotic genes, Bcl-2 and Bcl-xl (Supplemen-
tary Fig. S1c, d), were also induced during diet-induced
obesity. But the levels of Bcl-2 mRNA were signiﬁcantly
dropped in the TG2 null mice kept on HFD as compared
to their wild type counterparts. On the other hand, the
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anti-apoptotic Mcl-1 levels were decreased (Supplemen-
tary Fig. S1e), while the expression of TG2 was not altered
in the gWAT adipocytes during diet-induced obesity
(Supplementary Fig. S1f).
Altogether these data are indicative for more diet-
induced adipocyte death in the gWAT of mice kept on
HFD in the absence of TG2. Indeed, in the gWAT of TG2
null mice kept on either HSD or HFD signiﬁcantly more
dying cells were detected than in their wild type coun-
terparts (Supplementary Fig. S1g) by identifying dead
adipocytes as labeled by CLS16,29.
Loss of TG2 enhances hepatic steatosis and insulin
resistance in mice during diet-induced obesity
Since increased gonadal fat apoptosis and high pro-
inﬂammatory cytokine production are associated with
ectopic fat storage including hepatic steatosis10 and
insulin resistance16, we measured the development of
hepatic steatosis, alterations in glucose tolerance and in
insulin resistance in these mice. Together with the
enhanced gWAT adipocyte apoptosis (Fig. 1b and Sup-
plementary Fig. S1), in TG2 null mice kept on HFD both
the liver weight (Supplementary Fig. S2a) and the
Fig. 1 Loss of TG2 does not affect weight gain during diet-induced obesity, but enhances the pro-inﬂammatory cytokine production by
the gonadal white adipocytes and adipose tissue macrophages. a Body weights of wild type and TG2 null mice fed on normal (ND), high-
sucrose/low-fat (HSD) or high-sucrose/high-fat (HFD) diet at the end of the feeding period. b Gonadal fat weights of wild type and TG2 null mice fed
on ND, HSD or HFD at the end of the feeding period. c Adiponectin, resistin, TNF-α, MCP-1, and leptin relative gene expression levels of gWAT
adipocytes in wild type and TG2 null mice fed on ND, HSD or HFD determined by qRT-PCR at the end of the feeding period. GAPDH was used as
reference gene. d TG2, IL-1β, IL-6, TNF-α, MCP-1, and resistin relative gene expression levels of gWAT macrophages in wild type and TG2 null mice fed
on ND, HSD or HFD determined by qRT-PCR at the end of the feeding period. GAPDH was used as a reference gene. Results are expressed as mean ±
SD (n= 8 mice per group). Statistical signiﬁcance was evaluated by one-way ANOVA test (*p < 0.05)
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triacylglycerol content of the livers (Supplementary
Fig. S2b) were signiﬁcantly higher than that of the wild
type mice kept on HFD indicating translocation of more
lipids from the gonadal fat into the liver. Tissue sections
of livers stained with haematoxylin eosin conﬁrmed these
ﬁndings (Supplementary Fig. S2c).
Glucose tolerance tests demonstrated that as compared
to mice fed on ND, HSD and HFD decreases the glucose
tolerance. However, loss of TG2 did not worsen the
results of the glucose tolerance tests (Supplementary Fig.
S2d). Based on insulin tolerance tests, however, animals
lacking TG2 fed on HFD are more insulin resistant
(Supplementary Fig. S2e). These results were corrobo-
rated by enhanced fasting plasma insulin levels as com-
pared to their wild type counterparts (Supplementary Fig.
S2f). Altogether these data indicate that similar to SLE7 or
atherosclerosis30, loss of TG2 sensitizes also for the
development of obesity-induced inﬂammation and that of
its consequences.
Loss of TG2 in non-bone marrow-related cells leads to
enhanced circulating plasma insulin levels and insulin
resistance
TG2 is expressed not only by macrophages, but also by
adipocytes31 and hepatocytes32. To determine, whether
loss of TG2 in bone marrow-derived cells or in other cell
types is responsible for the above changes, wild type or
TG2 null mice were terminally irradiated, and their bone
marrow was replaced by a bone marrow originated from
either wild type or TG2 null mice in each combination.
To conﬁrm successful ablation and reconstitution, we
involved wild type BoyJ (a CD57BL/6 variant strain) mice
in these experiments, which express the CD45.1 allelic
variant of CD45, while C57BL/6 mice are CD45.2 positive.
Hematologic and ﬂow cytometric analysis of these mice
following bone marrow transplantation demonstrated a
leukocyte repopulation over 95%.
Irradiated CD57BL/6 mice gained signiﬁcantly less
weight, than their non-irradiated counterparts by the end
of the 16 weeks feeding (Supplementary Fig. S3a), in line
with previously published studies33,34. As compared to the
wild type counterparts, loss of TG2 in the non-bone
marrow-derived cells did not affect signiﬁcantly the per-
centage of dying adipocytes, the gonadal weight, gWAT
adipocyte Bid expression, liver weight, liver triacylglycerol
content or adipocyte pro-inﬂammatory cytokine or adi-
pokine mRNA expression either, with the exception of
TNF-α (Supplementary Fig. S3b–h). On the other hand,
the amount of resistin and IL-6 produced by adipose
tissue macrophages were signiﬁcantly higher in mice
lacking TG2 in in the non-bone marrow-derived cells
with no alterations in their TNF-α or MCP-1 production
(Supplementary Fig. S3i). In addition, we could detect
signiﬁcantly increased fasting circulating plasma insulin
levels and increased insulin resistance by using insulin
tolerance test (Supplementary Fig. S3i, k). Altogether our
data indicate that loss of TG2 in non-bone marrow-
derived cells induces early insulin resistance without sig-
niﬁcantly affecting the development of adipocyte cell
death, inﬂammation and hepatic steatosis induced
by HFD.
Loss of TG2 from bone marrow-derived cells is responsible
for the obesity-related adipocyte cell death, inﬂammation
and hepatic steatosis in TG2 null mice
Absence of TG2 in bone marrow-derived cells, however,
promoted adipocyte death in the gWAT of mice exposed
to HFD, compared to mice transplanted with wild type
bone marrow (Fig. 2a), possibly due to the enhanced TNF-
α24,25and leptin26 production in these mice. In addition,
signiﬁcantly larger gonadal fat weight (Fig. 2b), increased
liver weight and TAG content (Fig. 2c, d) could be
detected in animals lacking TG2 in the bone marrow
compartment. Increased hepatic steatosis was conﬁrmed
by haematoxylin eosin stained liver sections as well
(Fig. 2e). In line with these data, in the absence of bone
marrow-derived cells' TG2 a signiﬁcantly higher expres-
sion of adipose tissue TNF-α, IL-6, MCP-1, leptin and Bid
mRNA-s were detected in mice exposed to HFD (Fig. 2f).
Similarly, gWAT macrophage IL-6, MCP-1, TNFαmRNA
levels were also signiﬁcantly higher in the absence of TG2
(Fig. 2g). As shown later in Fig. 5j, circulating plasma
levels were also higher in the absence of bone marrow-
derived cells' TG2. Taken together, our data indicate that
as compared to wild type mice, loss of TG2 from bone
marrow-derived cells drives in TG2 null mice the
enhanced inﬂammation and the more severe pathological
consequences of HFD-feeding.
Loss of TG2 in macrophages results in a more efﬁcient
lysosomal exocytosis
Since our initial hypothesis was that the enhanced
obesity-related inﬂammation in TG2 null mice is the result
of impaired apoptotic cell phagocytosis, we decided to
determine whether macrophage TG2 is required for the
clearance of apoptotic adipocytes. For this purpose, adi-
pocytes differentiated from 3T3 ﬁbroblasts were made
apoptotic using serum deprivation, exposed to both wild
type and TG2 null bone marrow-derived macrophages and
their clearance as a function of time was followed by laser
scanning cytometry. Surprisingly, as shown in Fig. 3 and
Supplementary Video 1–4, loss of macrophage TG2 did
not delay, but accelerated lysosomal exocytosis of dead
adipocytes. We have revealed that adipocytes entering
apoptosis form ﬁrst lipid-containing vesicles surrounded
by phosphatidylserine positive membranes indicative of
cell death (Fig. 3a). Macrophages attach to the dead adi-
pocyte as it was described15, and continuously engulf these
Sághy et al. Cell Death and Disease          (2019) 10:439 Page 4 of 14
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Fig. 2 (See legend on next page.)
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lipid-containing vesicles. One wild type macrophage acting
on one dead adipocyte keeps taking up these vesicles
during the whole 5 h time frame of the video (Fig. 3b, c,
Supplementary Video 1 and 2), but does not complete the
clearing. TG2 null macrophages, however, take up these
lipid-containing vesicles (Fig. 3d–f, Supplementary Video
2 and 3), and trigger the initiation of the classical apoptosis
program characterized by membrane blebbing much fas-
ter. After the whole cytosolic content of the adipocyte is
cleared, TG2 null macrophages digest ﬁnally the degrading
nucleus (Fig. 3g). None of the wild type adipocytes could
reach this ﬁnal engulfment stage during the video time
frame (Supplementary Video 2).
Metabolically activated TG2 null macrophages produce
more pro-inﬂammatory cytokines than their wild type
counterparts due to enhanced c-Src signaling
Previous studies have demonstrated that in the absence
of TG2 integrin β3 signaling is altered leading to enhanced
c-Src tyrosine kinase activity35. Accordingly, in TG2 null
macrophages the amount of phosphorylated c-Src, β3
integrin levels and c-Src-dependent integrin β3 phos-
phorylation are enhanced leading to decreased basal IκB
levels, and consequently to enhanced pro-inﬂammatory
cytokine transcription following exposure to lipopoly-
saccharide36. Similar to lipopolysaccharide, palmitate was
also shown to activate TLR417 and c-Src37. Thus we
determined the pSrc levels in MMe macrophages that we
generated in vitro as it was previously described16, and
found increased levels in the absence of TG2 (Fig. 4a).
Next we determined the mRNA levels of integrin β3 in
gWAT macrophages and found that its levels are
increased during HSD and HFD, and both the basal and
the HSD/HFD-induced levels are signiﬁcantly higher in
the absence of TG2 (Fig. 4b). Similarly, in the absence of
TG2 we detected a signiﬁcantly increased expression of
integrin β3 in MMe macrophages as well (Fig. 4c).
Induction of integrin β3 expression in MMe macrophages
was completely c-Src-dependent, as PP2, a Src inhibitor,
prevented it.
Metabolic activation also induced signiﬁcantly higher
TNF-α, IL-1β, and IL-6 mRNA levels in TG2 null MMe
macrophages than in the wild type ones (Fig. 4d–f). In
addition, the PP2 Src inhibitor and the integrin receptor
inhibitor RGD peptide inhibited the induction of pro-
inﬂammatory cytokine formation both in wild type and in
TG2 null MMe macrophages, and in the presence of these
inhibitors no difference in their metabolic activation-
induced pro-inﬂammatory cytokine induction was found.
These data conﬁrm that TG2 null macrophages are more
sensitive to inﬂammatory stimulation, and this is related
to an enhanced integrin β3/ c-Src signaling.
LXR agonist treatment reverts the HFD-induced phenotype
in mice lacking TG2 in bone marrow-derived cells with less
hepatic steatosis than in wild type mice
Liver X receptors (LXR) are nuclear receptors that play
a key role in regulating whole-body cholesterol, fatty acid
and glucose metabolism38. Activation of LXR receptors is
also known to strongly suppress macrophage inﬂamma-
tion39. Though LXR agonist treatment has been shown to
affect metabolism signiﬁcantly during diet-induced obe-
sity resulting in attenuated weight gain, induction of white
adipocyte lipolysis and fatty acid oxidation40, hepatic
steatosis41 and improved insulin sensitivity42,43, we rea-
soned, if loss of TG2 in macrophages affects primarily
inﬂammation, LXR agonist treatment will result in a
similar phenotype in mice carrying and in mice lacking
TG2 in bone marrow-derived cells exposed to HFD.
Thus, we exposed bone marrow transplanted mice
expressing or not TG2 in their bone marrow-derived cells
to the LXR agonist GW3965 mixed with their high fat
containing food during the whole feeding period, as
described44. In agreement with a previous publication42,
LXR agonist treatment prevented body (Fig. 5a) and
gonadal fat weight (Fig. 5b) gain in HFD-exposed mice.
This was related to an enhanced white adipocyte apop-
tosis assessed by the enhanced Bid and Bim expression of
gWAT adipocytes (Fig. 5c). In contrast, the percentage of
dying adipocytes observed on tissue sections decreased in
(see ﬁgure on previous page)
Fig. 2 Loss of TG2 in BMD cells promotes adipocyte cell death, inﬂammation and hepatic steatosis in mice fed on HFD. a Confocal images of
gWAT collected from BoyJ mice transplanted with the bone marrow of either TG2+/+ or TG2−/− mice at the end of the HFD feeding period. Parafﬁn-
embedded gWAT slides were stained with the non-speciﬁcally labeling anti-digoxin antibody, anti-F4/80 antibody and DAPI to visualize adipocytes,
macrophages, and nuclei under confocal microscopy. Scale bar, 100 μm. CLS cells in ﬁelds from randomly selected sections of three different mice in
each group were quantiﬁed. Results are expressed as mean ± SD (n= 3 mice per group). Statistical signiﬁcance was evaluated by 2-tailed unpaired
Student’s t-test (*p < 0.05). b Weights of gWAT from the mice described in (a). c Liver weights from the same mice. d Liver triacylglycerol contents
from the same mice determined from saponiﬁed, neutralized liver extracts by glycerol enzymatic assay. e Parafﬁn-embedded liver tissue slides from
the same mice stained with H&E to visualize tissue architecture. One representative series of three are shown. Scale bar, 250 μm. f Inﬂammatory
cytokine, leptin and Bid relative gene expression levels of gWAT adipocytes from the same mice determined by qRT-PCR using GAPDH as a reference
gene. g Inﬂammatory cytokine and resistin relative gene expression levels of gWAT macrophages from the same mice determined by qRT-PCR using
GAPDH as a reference gene. Results are expressed as mean ± SD (n= 8 mice per group). Statistical signiﬁcance was evaluated by one-way ANOVA
(*p < 0.05)
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Fig. 3 Clearance of apoptotic adipocytes is faster by TG2 null macrophages than by their wild type counterparts. a Apoptotic adipocytes
form lipid-containing vesicles surrounded by phosphatidylserine positive membrane on their cell surface. Laser scanning cytometric image of
apoptotic 3T3 adipocytes induced to die by serum withdrawal for 24 h and stained for lipids with Nile red (red) and for phosphatidylserine with FITC-
labeled Annexin V (green). Scale bar, 100 μm. b 3T3 adipocytes induced to die by serum withdrawal for 24 h were stained for lipids with Nile red (red)
and exposed to wild type BMDMs stained with vital Hoechst DNA dye for nuclei (blue). Apoptotic adipocyte clearance was followed for 5 h by laser
scanning microscopy. First and last images from the Supplementary video 2 demonstrating the state of clearance for several apoptotic adipocyte/
macrophage cell pairs at the end of the 5 h period. Please, note that apoptotic adipocytes shrink very slow (adipocyte 4 and 6) or not yet in the
presence of wild type macrophages. c One apoptotic adipocyte and one wild type macrophage pair (from the Supplementary video 1)
demonstrating the process of lysosomal exocytosis. 3T3 adipocytes induced to die by serum withdrawal for 24 h were stained for lipids with Nile red
and exposed to wild type BMDMs stained with vital Hoechst DNA dye for nuclei (blue). Apoptotic adipocyte clearance was followed for 5 h by laser
scanning microscopy. Yellow arrows indicate lipid-containing vesicle uptake by macrophages, green arrows point to vesicles already in the
macrophage. The fact that the cytosol of macrophage contains red vesicles indicates lipid uptake from the adipocyte. d One apoptotic adipocyte and
one TG2 null macrophage pair (from the video 3) demonstrating the process of the apoptotic adipocyte uptake by TG2 null macrophages. 3T3
adipocytes induced to die by serum withdrawal for 24 h were stained for lipids with Nile red and exposed to TG2 null BMDMs stained with vital
Hoechst DNA dye for nuclei (blue). Apoptotic adipocyte clearance was followed for 5 h by laser scanning microscopy. Due to the fast vesicle uptake,
the cytosol of the TG2 null macrophage is full with red vesicles making difﬁcult to see the border between the adipocyte and the macrophage.
Please, note apoptotic adipocyte cell membrane blebbing and the shrinkage of the adipocyte on the last image. e To visualize macrophages and
adipocytes better, this is a laser scanning cytometric image of apoptotic 3T3 adipocytes induced to die by serum withdrawal for 24 h stained for lipids
with Nile red and being engulfed by TG2 null BMDMs stained with vital Hoechst DNA dye for nuclei (blue) and CFDA for cytosol (green) after 4 h of
phagocytosis. Upper panel shows the image without the red color of fat, lower panel shows all the colors together. Please note, that the green
cytosol of BMDMs becomes yellow due to lipid uptake as the red and green colors overlap. Arrow indicates a shrinked blebbing adipocyte. Scale bar
20 μm. f 3T3 adipocytes induced to die by serum withdrawal for 24 h were stained for lipids with Nile red and exposed to TG2 null BMDMs stained
with vital Hoechst DNA dye for nuclei (blue). Apoptotic adipocyte clearance was followed for 5 h by laser scanning microscopy. First and large images
from the Supplementary video 4 demonstrating the state of clearance for several apoptotic adipocyte/macrophage cell pairs at the end of the 5 h
period. Please, note that all the labeled adipocytes shrink and bleb. g After completing lysosomal exocytosis TG2 null macrophages engulf adipocyte
nuclei. Laser scanning cytometric image of 3T3 adipocytes induced to die by serum withdrawal for 24 h stained for lipids with Nile red and exposed
to TG2 null BMDMs stained with vital Hoechst DNA dye for nuclei (blue). At this stage of adipocyte clearance, the Hoechst slightly stains the
adipocyte nucleus as well. Yellow arrow indicates the last lipid-containing vesicles’ uptake by macrophage A. Green arrows indicate nuclei taken up
by macrophage B. Scale bar, 20 μm
Fig. 4 Metabolically activated TG2 null macrophages produce more pro-inﬂammatory cytokines than their wild type counterparts due to
enhanced c-Src signaling. a c-Src and p-Src levels of wild type and TG2 null metabolically activated BMDMs determined by Western blot analysis
using β-actin as reference protein. b Relative gene expression levels of integrin β3 in gWAT macrophages from wild type and TG2 null mice kept on
ND, HSD or HFD at the end of the feeding period determined by qRT-PCR using GAPDH as a reference gene. c–f Relative gene expression levels of
integrin β3, TNF-α, IL-1β, and IL-6 in metabolically activated wild type or TG2 null BMDMs alone or in the presence of 2 μM PP2 or 0.5 mg/ml RGD
peptide determined by qRT-PCR using GAPDH as a reference gene. Results are expressed as mean ± SD (n= 8 mice per group, n= 4 for
metabolically activated macrophages). Statistical signiﬁcance was evaluated by two-way ANOVA (*p < 0.05)
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the gonadal fat of LXR-treated mice, if TG2 was missing
from the bone marrow-derived cells (Fig. 5d), perhaps due
to their more efﬁcient clearance. Similarly, signiﬁcantly
increased LXR activation-related hepatic steatosis was
detected only in wild type mice (Fig. 5e–g). LXR agonist-
treated TG2 null gWAT macrophages produced sig-
niﬁcantly less MCP-1 and resistin, than their wild type
counterparts (Fig. 5h), while the gWAT adipocytes from
the same mice signiﬁcantly more adiponectin (Fig. 5c)
reﬂecting an improved insulin sensitivity. Indeed, though
Fig. 5 (See legend on next page.)
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there was no difference in the fasting circulating plasma
insulin levels in the LXR agonist treated mice (Fig. 5i),
animals lacking TG2 in bone marrow-derived cells,
showed increased insulin sensitivity (Fig. 5j).
Discussion
Previous studies have demonstrated that impaired
clearance of apoptotic cells is associated with the devel-
opment of various chronic inﬂammatory diseases6. Since
TG2 has been shown to participate in the apoptotic cell
clearance4,7, and obesity is associated with enhanced
adipocyte apoptosis, we decided to investigate whether
loss of TG2 affects diet-induced obesity-related patholo-
gies. Data presented in this paper indicate that loss of TG2
indeed enhances obesity-related pathologies such as adi-
pose tissue inﬂammation, adipocyte death, hepatic stea-
tosis and insulin resistance in mice exposed to either HSD
or to HFD, and all this is a result of the loss of TG2 from
bone marrow-derived cells.
Since our hypothesis was that the enhanced inﬂamma-
tion in TG2 null mice is related to impaired apoptotic cell
clearance, we tested whether TG2 was also required for
the clearance of the large, lipid-rich apoptotic adipocytes.
Since macrophages were reported to interact only with
dead adipocytes and the process involved actin poly-
merization15, we expected that TG2 might be involved in
the process by promoting possible integrin β3/apoptotic
adipocyte interaction, as it does during the classical
efferocytosis process4. To our surprise, however, we found
that dead adipocyte clearance is more effective by TG2
null macrophages. Our results clearly demonstrate that
the apoptosis program of adipocytes is initiated with
packing the cytosolic content into lipid-rich extracellular
vesicles covered by phosphatidylserine positive mem-
brane, and the lysosomal exocytosis of macrophages is a
process of a continuous uptake of these vesicles that,
according to Haka et al., might occur directly into the
lysosome15. It is interesting to note that while we were
writing this paper, it was published that living adipocytes
also release lipid-containing extracellular vesicles (exo-
somes) that are taken up by the surrounding macrophages
and the exosomes contributes to the macrophage meta-
bolic programming45.
Since TG2 null macrophages are much more efﬁcient in
lysosomal exocytosis, impaired clearance of dead adipo-
cytes cannot explain the observed HFD-induced pheno-
type of TG2 null mice, though we cannot exclude that
enhanced lipid uptake itself might be pro-inﬂammatory.
However, we could demonstrate that metabolically acti-
vated TG2 null macrophages produce more pro-
inﬂammatory cytokines due to their enhanced integrin
β3/c-Src signaling
35,36. Our observations are in line with
other reports, which also demonstrated that αvβ3 integrin
signaling can induce NFκB activation in macrophages46,
and that c-Src activity in macrophages is associated with
various inﬂammatory responses47.
Interestingly, we found that both pro-inﬂammatory
cytokine formation and lysosomal exocytosis, both TLR2-
dependent16, were enhanced in TG2 null macrophages.
TLR2 ligands are molecules with diacyl and triacylglycerol
moieties48. Integrin β3 is part of the pre-formed TLR2/
TLR1 signaling complex and is essential for triacyl lipo-
peptide engagement of TLR2 by recruiting triacyl lipo-
peptide bound to vitronectin49. In addition, αvβ3-integrin
signaling can boost the MYD88-dependent
TLR2 signaling50. What is more, phosphatidylserine
positive vesicles were already shown to be taken up by
MFG-E8/integrin β3-dependent manner at least by den-
dritic cells51. Thus enhanced integrin β3 expression and
signaling might be the explanation for the enhanced
lysosomal exocytosis of TG2 null macrophages.
Finally, we also compared the response of mice to LXR
agonist treatment during HFD-induced obesity with the
expectation that after attenuation of adipose tissue
inﬂammation the phenotype of mice carrying or not TG2
in their bone marrow-derived cells will be similar. LXR
agonist treatment prevented HFD-induced obesity in both
types of mice. In addition, as it was reported by others42,
(see ﬁgure on previous page)
Fig. 5 LXR agonist treatment reverts HFD-induced obesity with less hepatic steatosis in mice lacking TG2 in the bone marrow- derived
cells. a BMI of BoyJ mice transplanted with the bone marrow of either TG2+/+ or TG2−/− mice at the end of the 16-week HFD feeding period
combined or not with the LXR agonist GW3965 (20 mg/kg/day) treatment. b gWAT weights of the same mice. c Relative gene expressions of Bid,
Bim, and adiponectin of gWAT adipocytes from the same mice determined by qRT-PCR using GAPDH as a reference gene. d Confocal images of
gWAT collected from the same mice. Parafﬁn-embedded gWAT slides were stained with the non-speciﬁcally labeling anti-digoxin antibody, anti-F4/
80 antibody and DAPI to visualize adipocytes, macrophages, and nuclei under confocal microscopy. Scale bar, 100 μm. CLS cells in ﬁelds from
randomly selected sections of three different mice in each group were quantiﬁed. Results are expressed as mean ± SD (n= 3 mice per group).
Statistical signiﬁcance was evaluated by 2-tailed unpaired Student’s t-test (*p < 0.05). e Liver weights of the same mice. f Liver triacylglycerol contents
from the same mice determined from saponiﬁed, neutralized liver extracts by glycerol enzymatic assay. g Parafﬁn-embedded liver tissue slides from
the same mice stained with H&E to visualize tissue architecture. One representative series of three are shown. Scale bar, 250 μm. h MCP-1, IL-6, and
resistin relative gene expression levels of gWAT macrophages from the same mice determined by qRT-PCR using GAPDH as a reference gene.
i Serum insulin levels determined by Mouse Insulin ELISA kit. j Insulin resistance values of the same mice. Insulin resistance test was performed on
week 15 (6 h fasting followed by intraperitoneal administration of 0.75 IU/bwkg insulin). Data are presented as mean ± SD (n= 8 mice per group).
Statistical signiﬁcance was evaluated by two-way ANOVA (*p < 0.05)
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we also detected enhanced gWAT adipocyte apoptosis
and increased hepatic steatosis in LXR agonist treated
mice. Lack of gonadal weight gain as a result of LXR
treatment was reported to be the consequence of the LXR
agonist-induced activation of adipocyte LXRα which is
known to promote lipolysis and fatty acid oxidation in
adipose tissue41 leading ﬁnally to reduced adipocyte cell
number. While, however, the rate of adipocyte apoptosis,
based on the mRNA expression levels of Bid, was not
higher in LXR agonist-treated wild type mice, their
hepatic steatosis was signiﬁcantly more pronounced than
that of the LXR agonist-treated mice in which TG2 was
absent from the bone marrow-derived cells. Previous
studies indicated that the LXR agonist-induced hepatic
steatosis is the result of activation of hepatocyte LXRα
which triggers SREBP-c1-dependent triacylglycerol
synthesis41,52. However, in our mice there was no differ-
ence in the genotype of the hepatocytes. Thus our
observations indicate that TG2 null macrophages can
better buffer metabolic tissues from the damage caused by
ectopic accumulation of saturated free fatty acids53 very
likely due to their enhanced lipid handling. Thus it is
interesting to speculate whether LXR agonist treatment in
combination with enhancing lysosomal exocytosis could
be a therapeutic strategy in obesity.
Materials and methods
Animals and diets
Eight-week-old male TG2 deﬁcient54 and wild type mice
on a C57Bl/6 background generated from heterozygous
parents were housed in separated cages (with water and
food ad libitum) during the 16 weeks of feeding experi-
ment. In the ﬁrst 2 weeks, animals were kept on high-
sucrose/low-fat (HSD; 10% kcal% fat; 17% kcal% sucrose;
Research Diets Inc., D12450H) After this run-in period,
mice were divided into two groups: the HSD group
remained on HSD, whereas the HFD group received high-
sucrose/high-fat (HFD; 45% kcal% fat, 17% kcal% sucrose;
Research Diets Inc., D12451) diet during the following
14 weeks. The control group of mice were kept all the
time on normal diet (ND; 13% kcal% fat; 4.6% kcal%
sucrose; Special Diets Services, VRF1 (P)). Bone marrow
transplanted (BMT) mice were maintained in a speciﬁc-
pathogen-free status (autoclaved top ﬁlter cages) for the
entire course of experimentation, and antibiotics (amox-
icillin antibiotic, clavulanic acid, 500mg/125mg l−1 of
drinking water) were administered in the drinking water
following 4 weeks post-transplantation. Following 2 weeks
of ND after BMT, they were kept on HFD diet for
16 weeks. For LXR ligand treatment in vivo, mice were fed
after the bone marrow transplantation on HFD supple-
mented with 20mg/kg/day GW3965 (AbMole, M1929) as
described above. Mice were maintained under a 12 h light:
12 h darkness cycle and had access to food and water ad
libitum. The body weight and food intake of the animals
were registered weekly. For tissue collection, mice were
killed by isoﬂurane overdose at week 17 in accordance to
the University of Debrecen. Study protocols were
approved by the Animal Care Committee of the Uni-
versity of Debrecen (DEMÁB).
Bone marrow transplantation
Recipient BoyJ, TG2 null and TG2+/+ wild mice
(7 weeks old, males) were irradiated with 11 Gy using a
Theratron 780C cobalt unit for the ablation of the reci-
pient bone marrow. The animals to be irradiated were
immobilized using a circular cage (mouse pie cage) that
could hold up to 11 mice (alert mice). Following irradia-
tion, isolated bone marrow cells (in sterile RPMI-1640
medium) ﬂushed out the femur, tibia, and humerus from
donor BoyJ, TG2 null or TG2+/+ mice were transplanted
into the recipient mice by retro-orbital injection (20 × 106
bone marrow (BM) cells per mouse). This experimental
BMT CD45 congenic model allowed us to detect donor,
competitor and host contributions in hematopoiesis and
repopulation efﬁciency of donor cells (congenic mice with
CD45.1 versus CD45.2). The CD45.1 and CD45.2 con-
tribution were then detected by ﬂow cytometry usually
8–12 weeks following BMT. In short a cut at the tail tip of
the mice provided a drop of blood that was placed into
0.5 ml phosphate-buffered saline (PBS)+ 1% fetal bovine
serum+ 10 U ml−1 heparin buffer (Sigma Aldrich H3393)
(samples kept on ice). The cells were directly stained by
2 μl mouse anti-mouse CD45.2-FITC (clone 104) and 2 μl
rat anti-mouse GR1-PE (clone RB6-8C5) antibodies (BD
Pharmingen) and incubated on ice for 30min. After two
washes with ice-cold PBS–fetal bovine serum–heparin
buffer, cells were resuspended in 0.5–1 ml BD FACS lys-
ing solution (BD cat no. 349202), incubated for 5 min at
RT then centrifuged (400 g, 5 min, 4 °C). The double
stained samples were run on FACS (BD FACS Calibur)
and the ratio of donor cells was determined. The repo-
pulation was over 95% gated on the granulocyte fraction.
Isolation and metabolic activation of BMDMs
Bone marrow cells were isolated from femurs of
3–6 months old male TG2 null mice and their wild type
counterparts. Bone marrow macrophages (BMDMs) were
differentiated in DMEM supplemented with 10% FBS
(12106C), 2 mM L-glutamine (G7513), 1 mM Na-
pyruvate (S8636), 50 μM 2-mercaptoethanol (M3148)
and 100 U/ml penicillin/100 μg/ml streptomycin (P4333)
all from Sigma-Aldrich and 10% L929 ﬁbroblast condi-
tioned media for 7 days. For metabolic activation, differ-
entiated macrophages were treated with a combination of
30 mM D-glucose (G8270), 10 nM insulin (12643) and
0.4 mM sodium-palmitate (P9767) all from Sigma-Aldrich
for 24 h (16). Sodium palmitate was prepared by diluting a
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200mM stock solution in 70% ethanol into 10% fatty acid-
free, low-endotoxin BSA (Sigma Aldrich, A8806 adjusted
to pH 7.4) to obtain a 5 mM palmitate-BSA stock solution
that was ﬁltered using a 0.22-μm low-protein binding
ﬁlter (Millipore). BSA/ethanol was used in control treat-
ments during the protocol. In some experiments during
the 24 h metabolic activation BMDMs were treated with
PP2 (Sigma Aldrich, 529573), a reversible ATP-
competitive inhibitor of the Src family of protein tyr-
osine kinases, in 2 µM ﬁnal concentration or 0.5 mg/ml
RGD peptide (Cayman Chemical, 529573).
Cell culture and differentiation of 3T3 cells
3T3-L1 murine preadipocytes (ATCC:CL-173) were
maintained as subconﬂuent cultures in Dulbecco’s modiﬁed
Eagle’s medium (DMEM, Sigma-Aldrich) supplemented
with 4.5 g/l D-glucose, 2mM L-glutamine and 10% (v/v)
bovine calf serum. For differentiation, after 2 days post-
conﬂuency, differentiation was induced by addition of 2 μg/
ml insulin, 0.5mM isobutylmethylxanthine (Sigma-Aldrich,
I5879), and 0.25 μM dexamethasone (Sigma-Aldrich,
D4902). The cells were maintained in this medium for
3 days and then for 2 more days in medium supplemented
with 1 μg/ml insulin. After 10 days of differentiation, FBS
was omitted from the medium and the cells were main-
tained for another day in order to induce apoptosis55. The
basal cell death index was very low (<5%), but following
serum withdrawal the percentage of annexin V positive cells
increased signiﬁcantly (≥90 after 24 h).
Insulin resistance test, intraperitoneal glucose tolerance
test (IPGTT), insulin determination
Insulin resistance test and IPGTT was performed on
week 15 and 16, respectively. After a 6 h fasting period,
0.75 IU/bwkg insulin (ACTRAPID Penﬁll 100 IU/ml,
Novo Nordisk) or 2 g/bwkg glucose was injected intra-
peritoneally. Blood glucose levels were determined with
DCont Trend glucose monitor (DCont, Hungary) at the
indicated time points after insulin or glucose injection.
Plasma insulin levels were determined by Mouse Insulin
ELISA kit (ALPCO, 80-INSMS-E01) according to the
manufacturer's instructions.
Collection of tissue samples
At the end of the feeding phase, the animals were
sacriﬁced with isoﬂurane, body weight, body length, liver,
and gonadal white adipose tissue (gWAT) weight were
measured. Blood, liver, and gWATsamples were collected
for subsequent analysis. Blood samples were allowed to
clot and spun at 12.000 rpm for 15min to collect plasma.
For histological analysis, adipose tissue and liver samples
were ﬁxed in 4% paraformaldehyde; for gene expression
and liver triglyceride determination were frozen in liquid
nitrogen and stored at −80 °C prior to extraction.
Adipocyte and adipose tissue macrophage (ATM) isolation
gWAT tissue was dissected and washed and kept in
transport buffer (DMEM supplemented with 1%
Penicillin–Streptomycin solution and 1% bovine serum
albumin (BSA). The tissue was minced, digested for
30–60 min at 37 °C in digestion solution (HEPES buffer
(pH 7.4, H3375) supplemented with 20 g/L BSA and
0.5 g/L collagenase type 1 (C6885); all from Sigma-
Aldrich, and ﬁltered through a nylon ﬁlter (100 μm). After
a centrifugation step, adipocytes were collected and stored
at −80 °C prior to RNA isolation. After the removal of red
blood cells by hemolysis (ACK Lysing Buffer, Thermo
Fisher Scientiﬁc, A1049201) the stromal vascular cell
fraction was resuspended in staining buffer (PBS supple-
mented with 0.5% BSA and 2mM EDTA (Sigma-Aldrich,
E6758)). ATMs were isolated from SVCs using MACS
Technology (F4/80-based positive selection; (Miltenyi
Biotech, 130-097-050, 130-117-509) according to the
manufacturer’s instructions.
Liver triglyceride levels
Triglyceride concentrations were quantiﬁed in saponi-
ﬁed, neutralized liver extract (digested in ethanolic KOH
(Sigma-Aldrich, P5958) overnight at 55 °C by glycerol
enzymatic assay (Free Glycerol Reagent, Glycerol Stan-
dard Solution, Sigma-Aldrich, F6428, G7793) according to
the manufacturer's instructions.
Histology and immunohistochemistry
Hepatic tissues were ﬁxed in 4% neutral buffered for-
maldehyde (Sigma-Aldrich, F8775) and embedded in
parafﬁn. Parafﬁn sections were stained with hematoxylin-
eosin (H&E; Sigma-Aldrich, HT110116, GHS116) stain.
Histological sections were analyzed on Leica DMRB/E
light microscope (Heerbrugg, Switzerland).
After parafﬁn embedding, 6 µm thick sections were cut
from gWAT tissue samples. The sections were mounted
on glass slides, deparafﬁnized and kept in 10% normal goat
serum (Thermo Fisher Scientiﬁc, 31872) for 50min at
room temperature. The sections were ﬁrst incubated with
an antibody raised against the macrophage marker F4/80
in rat (diluted 1:1000, Hycult Biotech, HM1066), then
transferred into a solution of goat anti-rat IgG conjugated
with Alexa Fluor 555 (diluted 1:1000, Molecular Probes,
A21434). We have noticed that the ﬂuorescein-labeled
anti-digoxigenin antibody offered by the Apoptag ﬂuor-
escein kit (Millipore, S7110) has strong aspeciﬁc binding in
our adipocyte tissue sections. This aspeciﬁc signal was
used to visualize the cellular architecture of gWAT tissue.
The immunostained sections were covered with a Vecta-
shield Antifade Mounting Medium with DAPI (Vector
Laboratories, H-1200). The number of adipocytes and
nuclei was determined by ImageJ software, while the
number of CLS was counted manually.
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Confocal microscopy
Single 1-μm-thick optical sections were scanned with an
Olympus FV3000 confocal microscope. Scanning was
carried out with a ×40 oil-immersion lens (NA 1.3). The
confocal settings (laser power, confocal aperture, and
gain) were identical for all means, and care was taken to
ensure that no pixels corresponding to puncta immu-
nostained for the F4/80 macrophage marker were satu-
rated. The scanned images were processed by Adobe
Photoshop CS3 software and analyzed by ImageJ software.
RNA Isolation and real-time quantitative (RT-qPCR)
TRIzol reagent (UD-Genomed, URN0102) was used to
isolate total RNA from samples. cDNA was synthesized with
High-Capacity cDNA Archive Kit (Thermo Fisher Scientiﬁc,
4368813) according to the manufacturer's instruction. Gene
expression levels were determined with qRT-PCR using
FAM-MGB labeled Taq-Man probes (Thermo Fisher Sci-
entiﬁc) by Real-time PCR on Roche Light Cycler 480 plat-
form. Samples were run in triplicates. Expression values
were normalized to GAPDH housekeeping gene.
Time-lapse imaging microscopy
3T3-L1 originated adipocytes were stained with Nile red
to identify lipid droplets, while macrophages with Hoechst
33342 (Thermo Fischer Scientiﬁc, 62249) to recognize
macrophage nuclei and with 10 μM 5-carboxyﬂuorescein
diacetate (CFDA) (Sigma-Aldrich, C4916) to recognize
macrophage cytosol. Wild type or TG2 null macrophages
were layered on top of the apoptotic adipocytes in a ratio
of 5:1. The co-culture was placed in a temperature-,
humidity- and CO2-controlled, motorized Olympus IX-81
inverted microscope (Olympus America), which was
equipped with a cooled Hamamatsu ORCA-R2 (Hama-
matsu Photonics, Hamamatsu City, Japan) high-
resolution monochrome CCD camera and a DP21-CU
2-megapixel digital color camera (Olympus America).
Cells were monitored for 5 h and in every 5 min, an image
was taken. Data were converted into a video ﬁle with the
use of the Xcellence software (Olympus America). Lipid
contents of adipocytes induced to undergo apoptosis by
serum starvation were labeled by Nile red (Thermo Fisher
Scientiﬁc, N1142).
Western blot
Mme BMDMs were washed with PBS, dissociated by
lysis buffer (50mM Tris (T5941) pH 6.8, 2% SDS (L3771),
5% glycerol (G5516), 2 mM DTT (D0632), 2.5 mM EDTA,
2.5mM EGTA (E3889), all reagents from Sigma-Aldrich),
supplemented protease and phosphatase inhibitor cocktail
(Sigma-Aldrich, P8340, 524629). Samples were boiled for
10min with SDS-sample buffer at 100 °C. The samples
were separated by 12% SDS-PAGE and transferred to
PVDF membrane (Bio-Rad, 1620177). The membrane was
blocked with TBST buffer (10mM Tris, pH 8.0, 0.15M
NaCl (S7653), and 0.05% Tween 20 (P1379); all reagents
from Sigma-Aldrich) containing 5% BSA for 1 h at room
temperature and then probed with anti-phospho(Tyr416)-
Src, c-Src (Cells Signaling Technology, 2101, 2108) and
beta-actin (Sigma-Aldrich, 5441) primary antibodies
overnight at 4 °C. Beta-actin was used for the loading
control. After washing with TBST buffer, blots were
incubated with HRP-conjugated secondary antibodies for
1 h at room temperature. Proteins were detected with
chemiluminescence (Immobilon Western Chemilumines-
cent HRP Substrate, Merck Millipore, WBKLS0500). The
pixel density of bands was determined by Image J software.
Statistical analysis
Data are presented as mean ± SD for all data. All sta-
tistical analyses were performed using GraphPad Prism
6.01 and a P-value < 0.05 was considered as signiﬁcant and
is indicated by asterisk (*). For differences between 2
groups 2-tailed unpaired Student’s t-test, for comparisons
n > 2 groups one- ANOVA (with Turkey’s multiple com-
parisons test) was used. n= 8 mice/group were used for
the experiments except for BM transplanted population,
where n= 5 mice were investigated. For datasets split on
two independent factors, 2-way ANOVA was used.
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